| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-11 16:55:02 UTC |
|---|
| Updated at | 2022-05-11 16:55:02 UTC |
|---|
| NP-MRD ID | NP0087621 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione |
|---|
| Description | 17A,21-Dihydroxy-5b-pregnane-3,11,20-trione, also known as 4,5beta-dihydrocortisone or 5beta-pregnane-17alpha,21-diol-3,11,20-trione, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione is considered to be a steroid lipid molecule. 17A,21-Dihydroxy-5b-pregnane-3,11,20-trione is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Within humans, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione participates in a number of enzymatic reactions. In particular, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione can be converted into cortisone through its interaction with the enzyme 3-oxo-5-beta-steroid 4-dehydrogenase. In addition, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione can be biosynthesized from tetrahydrocortisone through its interaction with the enzyme aldo-keto reductase family 1 member C4. A 4,17a,21-Dihydroxy-5b-pregnane-3,11,20-trione that has beta- configuration at position 5. In humans, 17a,21-dihydroxy-5b-pregnane-3,11,20-trione is involved in the metabolic disorder called the 21-hydroxylase deficiency (cyp21) pathway. |
|---|
| Structure | [H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h12,14-15,18,22,26H,3-11H2,1-2H3/t12-,14+,15+,18-,19+,20+,21+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione | ChEBI | | 4,5beta-Dihydrocortisone | ChEBI | | 5-Dihydrocortisone | ChEBI | | 5beta-Pregnane-17alpha,21-diol-3,11,20-trione | ChEBI | | 17Α,21-dihydroxy-5β-pregnane-3,11,20-trione | Generator | | 4,5b-Dihydrocortisone | Generator | | 4,5Β-dihydrocortisone | Generator | | 5b-Pregnane-17a,21-diol-3,11,20-trione | Generator | | 5Β-pregnane-17α,21-diol-3,11,20-trione | Generator | | 17,21-Dihydroxy-5-beta-pregnane-3,11,20-trione | HMDB | | 17,21-Dihydroxy-5b-pregnane-3,11,20-trione | HMDB | | 4,5-b-Dihydrocortisone | HMDB | | 4,5-beta-Dihydrocortisone | HMDB | | 5 beta-Pregnan-17 alpha,21-dihydroxy-3,11,20-trione | HMDB | | 5 beta-Dihydrocortisone | HMDB |
|
|---|
| Chemical Formula | C21H30O5 |
|---|
| Average Mass | 362.4599 Da |
|---|
| Monoisotopic Mass | 362.20932 Da |
|---|
| IUPAC Name | (1S,2S,7R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,17-dione |
|---|
| Traditional Name | dihydrocortisone |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C |
|---|
| InChI Identifier | InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h12,14-15,18,22,26H,3-11H2,1-2H3/t12-,14+,15+,18-,19+,20+,21+/m1/s1 |
|---|
| InChI Key | YCLWEYIBFOLMEM-FNLRALKVSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Hydroxysteroids |
|---|
| Direct Parent | 21-hydroxysteroids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Progestogin-skeleton
- 21-hydroxysteroid
- 20-oxosteroid
- Pregnane-skeleton
- 3-oxosteroid
- 11-oxosteroid
- Oxosteroid
- 17-hydroxysteroid
- 3-oxo-5-beta-steroid
- Cyclic alcohol
- Tertiary alcohol
- Alpha-hydroxy ketone
- Ketone
- Cyclic ketone
- Alcohol
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Primary alcohol
- Carbonyl group
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | - 4,5-dihydrocortisone (CHEBI:18093 )
- C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives (C05469 )
- C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives (LMST02030095 )
|
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|